{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:32:48Z","timestamp":1759962768478,"version":"3.37.3"},"reference-count":53,"publisher":"Bentham Science Publishers Ltd.","issue":"28","funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["251512"],"award-info":[{"award-number":["251512"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006348","name":"Benem\u00e9rita Universidad Aut\u00f3noma de Puebla","doi-asserted-by":"publisher","award":["100518932 VIEP2019"],"award-info":[{"award-number":["100518932 VIEP2019"]}],"id":[{"id":"10.13039\/501100006348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2019,12,19]]},"abstract":"<jats:sec>\n<jats:title>Background::<\/jats:title>\n<jats:p>Candida species are in various parts of the human body as commensals. However,\nthey can cause local mucosal infections and, sometimes, systemic infections in which Candida\nspecies can spread to all major organs and colonize them.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective::<\/jats:title>\n<jats:p>For the effective treatment of the mucosal infections and systemic life-threatening fungal\ndiseases, a considerably large number of antifungal drugs have been developed and used for clinical\npurposes that comprise agents from four main drug classes: the polyenes, azoles, echinocandins, and\nantimetabolites.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method: :<\/jats:title>\n<jats:p>The synthesis of some of these drugs is available, allowing synthetic modification of the\nmolecules to improve the biological activity against Candida species. The synthetic methodology for\neach compound is reviewed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results: :<\/jats:title>\n<jats:p>The use of these compounds has caused a high-level resistance against these drugs, and therefore,\nnew antifungal substances have been described in the last years. The organic synthesis of the\nknown and new compounds is reported.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion: :<\/jats:title>\n<jats:p>This article summarizes the chemistry of the existing agents, both the old drugs and new\ndrugs, in the treatment of infections due to C. albicans, including the synthesis of the existing drugs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026619666191025153124","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T11:29:21Z","timestamp":1572002961000},"page":"2554-2566","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Chemistry of Drugs to Treat Candida albicans"],"prefix":"10.2174","volume":"19","author":[{"given":"Aurelio","family":"Ortiz","sequence":"first","affiliation":[{"name":"Facultad de Ciencias Quimicas, Benemerita Universidad Autonoma de Puebla, Pue, 72570, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estibaliz","family":"Sansinenea","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias Quimicas, Benemerita Universidad Autonoma de Puebla, Pue, 72570, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1016\/j.bmc.2012.04.045","volume":"20","author":"Kathiravan M.K.","year":"2012","unstructured":"Kathiravan M.K.; Salake A.B.; Chothe A.S.; Dudhe P.B.; Watode R.P.; Mukta M.S.; Gadhwe S.; The biology and chemistry of antifungal agents: a review. Bioorg Med Chem 2012,20(19),5678-5698","journal-title":"Bioorg Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2013\/763628","volume":"2013","author":"Kabir M.A.","year":"2013","unstructured":"Kabir M.A.; Ahmad Z.; Candida infections and their prevention. ISRN Prev Med 2013,2013,1-13","journal-title":"ISRN Prev Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/1568026618666180528121707","volume":"18","author":"Srivastava V.","year":"2018","unstructured":"Srivastava V.; Singla R.K.; Dubey A.K.; Emerging virulence, drug resistance and future anti-fungal drugs for candida pathogens. Curr Top Med Chem 2018,18(9),759-778","journal-title":"Curr Top Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1517\/14656566.2010.493875","volume":"11","author":"Moudgal V.","year":"2010","unstructured":"Moudgal V.; Sobel J.; Antifungals to treat Candida albicans. Expert Opin Pharmacother 2010,11(12),2037-2048","journal-title":"Expert Opin Pharmacother"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bcp.2016.11.019","volume":"133","author":"Campoy S.","year":"2017","unstructured":"Campoy S.; Adrio J.L.; Antifungals. Biochem Pharmacol 2017,133,86-96","journal-title":"Biochem Pharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mycmed.2016.10.002","volume":"27","author":"Zida A.","year":"2017","unstructured":"Zida A.; Bamba S.; Yacouba A.; Ouedraogo-Traore R.; Guiguemd\u00e9 R.T.; Anti-Candida albicans natural products, sources of new antifungal drugs: A review. J Mycol Med 2017,27(1),1-19","journal-title":"J Mycol Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","volume":"68","author":"Lemke A.","year":"2005","unstructured":"Lemke A.; Kiderlen A.F.; Kayser O.; Amphotericin B.; Amphotericin B.;  Appl Microbiol Biotechnol 2005,68(2),151-162","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1039\/b820743g","volume":"27","author":"Volmer A.A.","year":"2010","unstructured":"Volmer A.A.; Szpilman A.M.; Carreira E.M.; Synthesis and biological evaluation of amphotericin B derivatives. Nat Prod Rep 2010,27(9),1329-1349","journal-title":"Nat Prod Rep"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/0040-4039(96)00300-0","volume":"37","author":"Bonini C.","year":"1996","unstructured":"Bonini C.; Giugliano A.; Racioppi R.; Righi G.; Synthesis of the Ci-C~0 fragment of the macrolide antibiotic nystatin al from a chiral building block obtained via chemoenzymatic approach. Tetrahedron Lett 1996,37,2487","journal-title":"Tetrahedron Lett"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0040-4039(97)10455-5","volume":"39","author":"Schneider C.","year":"1998","unstructured":"Schneider C.; Rehfeuter M.; Enantioselective polyol synthesis via the cope rearrangement of chiral aldol products. A synthesis of the Cl-CIO-fragment of nystatin Al. Tetrahedron Lett 1998,39,9","journal-title":"Tetrahedron Lett"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1021\/jo990245y","volume":"64","author":"Solladi\u00e9 G.","year":"1999","unstructured":"Solladi\u00e9 G.; Wilb N.; Bauder C.; Bonini C.; Viggiani L.; Chiummiento L.; First stereocontrolled synthesis of the (3S,5R,7R,10R,11R)-C1-C13 fragment of nystatin A(1). J Org Chem 1999,64(15),5447-5452","journal-title":"J Org Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"11992","DOI":"10.1073\/pnas.0401552101","volume":"101","author":"Kadota I.","year":"2004","unstructured":"Kadota I.; Hu Y.; Packard G.K.; Rychnovsky S.D.; A unified approach to polyene macrolides: synthesis of candidin and nystatin polyols. Proc Natl Acad Sci USA 2004,101(33),11992-11995","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1470-9465.2004.00841.x","volume":"10","author":"Maertens J.A.","year":"2004","unstructured":"Maertens J.A.; History of the development of azole derivatives. Clin Microbiol Infect 2004,10(Suppl. 1),1-10","journal-title":"Clin Microbiol Infect"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1124\/mol.113.085902","volume":"84","author":"Mast N.","year":"2013","unstructured":"Mast N.; Zheng W.; Stout C.D.; Pikuleva I.A.; Antifungal azoles: structural insights into undesired tight binding to cholesterol metabolizing CYP46A1. Mol Pharmacol 2013,84(1),86-94","journal-title":"Mol Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1358\/dot.2015.51.12.2421058","volume":"51","author":"Peyton L.R.","year":"2015","unstructured":"Peyton L.R.; Gallagher S.; Hashemzadeh M.; Triazole antifungals: a review. Drugs Today (Barc) 2015,51(12),705-718","journal-title":"Drugs Today (Barc)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1586\/14787210.4.2.171","volume":"4","author":"Fothergill A.W.","year":"2006","unstructured":"Fothergill A.W.; Miconazole: A historical perspective. Expert Rev Anti Infect Ther 2006,4(2),171-175","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=17","first-page":"49","volume":"48","author":"Cuevas Yanez E.","year":"2004","unstructured":"Cuevas Yanez E.; Canul sanchez, A.; Serrano Becerra, J.M.; Muchowski, J.M.; Cruz Almanza, R. Synthesis of miconazole and analogs through a carbenoid intermediate. Rev Soc Qu\u00edm M\u00e9x 2004,48,49-52","journal-title":"Rev Soc Qu\u00edm M\u00e9x"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1021\/jo102459w","volume":"76","author":"Mangas-S\u00e1nchez J.","year":"2011","unstructured":"Mangas-S\u00e1nchez J.; Busto E.; Gotor-Fern\u00e1ndez V.; Malpartida F.; Gotor V.; Asymmetric chemoenzymatic synthesis of miconazole and econazole enantiomers. The importance of chirality in their biological evaluation. J Org Chem 2011,76(7),2115-2122","journal-title":"J Org Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0924-8579(93)90009-T","volume":"3","author":"Zervos M.","year":"1993","unstructured":"Zervos M.; Meunier F.; Fluconazole (Diflucan): A review. Int J Antimicrob Agents 1993,3(3),147-170","journal-title":"Int J Antimicrob Agents"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1021\/jo500369y","volume":"79","author":"Tamura K.","year":"2014","unstructured":"Tamura K.; Kumagai N.; Shibasaki M.; An enantioselective synthesis of the key intermediate for triazole antifungal agents; application to the catalytic asymmetric synthesis of efinaconazole (Jublia). J Org Chem 2014,79(7),3272-3278","journal-title":"J Org Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jac\/dkg117","volume":"51","author":"Letscher-Bru V.","year":"2003","unstructured":"Letscher-Bru V.; Herbrecht R.; Caspofungin: The first representative of a new antifungal class. J Antimicrob Chemother 2003,51(3),513-521","journal-title":"J Antimicrob Chemother"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ja.2008.3","volume":"62","author":"Hashimoto S.","year":"2009","unstructured":"Hashimoto S.; Micafungin: a sulfated echinocandin. J Antibiot (Tokyo) 2009,62(1),27-35","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/molecules23030520","volume":"23","author":"Abonia R.","year":"2018","unstructured":"Abonia R.; Garay A.; Castillo J.C.; Insuasty B.; Quiroga J.; Nogueras M.; Cobo J.; Butassi E.; Zacchino S.; Design of two alternative routes for the synthesis of naftifine and analogues as potential antifungal agents. Molecules 2018,23(3),520","journal-title":"Molecules"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1021\/jm00151a019","volume":"29","author":"St\u00fctz A.","year":"1986","unstructured":"St\u00fctz A.; Georgopoulos A.; Granitzer W.; Petranyi G.; Berney D.; Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics. J Med Chem 1986,29(1),112-125","journal-title":"J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0040-4039(00)61625-8","volume":"34","author":"Petasis N.A.","year":"1993","unstructured":"Petasis N.A.; Akritopoulou I.; The boronic acid Mannich reaction: A new method for the synthesis of geometrically pure allylamines. Tetrahedron Lett 1993,34,583-586","journal-title":"Tetrahedron Lett"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1021\/jo201105z","volume":"76","author":"Prediger P.","year":"2011","unstructured":"Prediger P.; Barbosa L.F.; G\u00e9nisson Y.; Correia C.R.; Substrate-directable Heck reactions with arenediazonium salts. The regio- and stereoselective arylation of allylamine derivatives and applications in the synthesis of naftifine and abamines. J Org Chem 2011,76(19),7737-7749","journal-title":"J Org Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0040-4039(95)02095-0","volume":"37","author":"Alami M.","year":"1996","unstructured":"Alami M.; Ferri F.; Gaslain Y.; A Two-step synthesis of terbinafine. Tetrahedron Lett 1996,37,57-58","journal-title":"Tetrahedron Lett"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jac\/46.2.171","volume":"46","author":"Vermes A.","year":"2000","unstructured":"Vermes A.; Guchelaar H.J.; Dankert J.; Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 2000,46(2),171-179","journal-title":"J Antimicrob Chemother"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1021\/acs.oprd.6b00420","volume":"21","author":"Harsanyi A.","year":"2017","unstructured":"Harsanyi A.; Conte A.; Pichon L.; Rabion A.; Grenier S.; Sandford G.; One-step continuous flow synthesis of antifungal WHO essential medicine flucytosine using fluorine. Org Process Res Dev 2017,21,273-276","journal-title":"Org Process Res Dev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1021\/ol060353o","volume":"8","author":"Paquet V.","year":"2006","unstructured":"Paquet V.; Carreira E.M.; Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine. Org Lett 2006,8(9),1807-1809","journal-title":"Org Lett"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejmech.2015.04.047","volume":"97","author":"Ram\u00edrez-Villalva A.","year":"2015","unstructured":"Ram\u00edrez-Villalva A.; Gonz\u00e1lez-Calder\u00f3n D.; Gonz\u00e1lez-Romero C.; Morales-Rodr\u00edguez M.; Jauregui-Rodr\u00edguez B.; Cuevas-Y\u00e1\u00f1ez E.; Fuentes-Ben\u00edtes A.; A facile synthesis of novel miconazole analogues and the evaluation of their antifungal activity. Eur J Med Chem 2015,97,275-279","journal-title":"Eur J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1039\/C5OB00590F","volume":"13","author":"Pore V.S.","year":"2015","unstructured":"Pore V.S.; Agalave S.G.; Singh P.; Shukla P.K.; Kumar V.; Siddiqi M.I.; Design and synthesis of new fluconazole analogues. Org Biomol Chem 2015,13(23),6551-6561","journal-title":"Org Biomol Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1021\/jm9707277","volume":"41","author":"Bartroli J.","year":"1998","unstructured":"Bartroli J.; Turmo E.; Alguer\u00f3 M.; Boncompte E.; Vericat M.L.; Conte L.; Ramis J.; Merlos M.; Garc\u00eda-Rafanell J.; Forn J.; New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones. J Med Chem 1998,41(11),1869-1882","journal-title":"J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1021\/ml300429p","volume":"4","author":"Guillon R.","year":"2013","unstructured":"Guillon R.; Pagniez F.; Picot C.; H\u00e9dou D.; Tonnerre A.; Chosson E.; Duflos M.; Besson T.; Log\u00e9 C.; Le Pape P.; Discovery of a novel broad-spectrum antifungal agent derived from albaconazole. ACS Med Chem Lett 2013,4(2),288-292","journal-title":"ACS Med Chem Lett"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1128\/AAC.02623-13","volume":"58","author":"Oliveira A.S.","year":"2014","unstructured":"Oliveira A.S.; Gaspar C.A.; Palmeira-de-Oliveira R.; Martinez-de-Oliveira J.; Palmeira-de-Oliveira A.; Anti-Candida activity of fluoxetine alone and combined with fluconazole: a synergistic action against fluconazole-resistant strains. Antimicrob Agents Chemother 2014,58(7),4224-4226","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1021\/jm049856v","volume":"47","author":"Silvestri R.","year":"2004","unstructured":"Silvestri R.; Artico M.; La Regina G.; Di Pasquali A.; De Martino G.; D\u2019Auria F.D.; Nencioni L.; Palamara A.T.; Imidazole analogues of fluoxetine, a novel class of anti-Candida agents. J Med Chem 2004,47(16),3924-3926","journal-title":"J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/cbdd.12809","volume":"88","author":"Bo\u017einovi\u0107 N.","year":"2016","unstructured":"Bo\u017einovi\u0107 N.; \u0160egan S.; Vojnovic S.; Pavic A.; \u0160olaja B.A.; Nikodinovic-Runic J.; Opsenica I.M.; Synthesis and anti-Candida activity of novel benzothiepino[3,2-c]pyridine derivatives. Chem Biol Drug Des 2016,88(6),795-806","journal-title":"Chem Biol Drug Des"},{"key":"ref=38","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902017000115239","volume":"53","author":"Radwan A.A.","year":"2017","unstructured":"Radwan A.A.; Alanazi F.K.; Al-Agamy M.H.; 1,3,4-Thiadiazole and 1,2,4-triazole-3(4H)-thione bearing salicylate moiety: synthesis and evaluation as anti-Candida albicans. Braz J Pharm Sci 2017,53","journal-title":"Braz J Pharm Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/molecules23030520","volume":"23","author":"Abonia R.","year":"2018","unstructured":"Abonia R.; Garay A.; Castillo J.C.; Insuasty B.; Quiroga J.; Nogueras M.; Cobo J.; Butassi E.; Zacchino S.; Design of two alternative routes for the synthesis of naftifine and analogues as potential antifungal agents. Molecules 2018,23(3),520","journal-title":"Molecules"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ijantimicag.2012.05.021","volume":"40","author":"Thibane V.S.","year":"2012","unstructured":"Thibane V.S.; Kock J.L.F.; Van Wyk P.W.J.; Ells R.; Pohl C.H.; Stearidonic acid acts in synergism with amphotericin B in inhibiting Candida albicans and Candida dubliniensis biofilms in vitro. Int J Antimicrob Agents 2012,40(3),284-285","journal-title":"Int J Antimicrob Agents"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/21505594.2015.1039885","volume":"6","author":"Cui J.","year":"2015","unstructured":"Cui J.; Ren B.; Tong Y.; Dai H.; Zhang L.; Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans. Virulence 2015,6(4),362-371","journal-title":"Virulence"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mycmed.2016.10.002","volume":"27","author":"Zida A.","year":"2017","unstructured":"Zida A.; Bamba S.; Yacouba A.; Ouedraogo-Traore R.; Guiguemd\u00e9 R.T.; Anti-Candida albicans natural products, sources of new antifungal drugs: A review. J Mycol Med 2017,27(1),1-19","journal-title":"J Mycol Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.biochi.2013.06.019","volume":"95","author":"Hwang J.H.","year":"2013","unstructured":"Hwang J.H.; Jin Q.; Woo E-R.; Lee D.G.; Antifungal property of hibicuslide C and its membrane-active mechanism in Candida albicans. Biochimie 2013,95(10),1917-1922","journal-title":"Biochimie"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/jam.12633","volume":"117","author":"Hwang J.H.","year":"2014","unstructured":"Hwang J.H.; Choi H.; Kim A.R.; Yun J.W.; Yu R.; Woo E-R.; Lee D.G.; Hibicuslide C-induced cell death in Candida albicans involves apoptosis mechanism. J Appl Microbiol 2014,117(5),1400-1411","journal-title":"J Appl Microbiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.7164\/antibiotics.49.547","volume":"49","author":"Gorman J.A.","year":"1996","unstructured":"Gorman J.A.; Chang L.P.; Clark J.; Gustavson D.R.; Lam K.S.; Mamber S.W.; Pirnik D.; Ricca C.; Fernandes P.B.; O\u2019Sullivan J.; Ascosteroside, a new antifungal agent from Ascotricha amphitricha. I. Taxonomy, fermentation and biological activities. J Antibiot (Tokyo) 1996,49(6),547-552","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"837","DOI":"10.7164\/antibiotics.51.837","volume":"51","author":"Harris G.H.","year":"1998","unstructured":"Harris G.H.; Shafiee A.; Cabello M.A.; Curotto J.E.; Genilloud O.; G\u00f6klen K.E.; Kurtz M.B.; Rosenbach M.; Salmon P.M.; Thornton R.A.; Zink D.L.; Mandala S.M.; Inhibition of fungal sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs. J Antibiot (Tokyo) 1998,51(9),837-844","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"9387","DOI":"10.1021\/jo701509r","volume":"72","author":"Parsons P.J.","year":"2007","unstructured":"Parsons P.J.; Pennicott L.; Eshelby J.; Goessman M.; Highton A.; Hitchcock P.; A total synthesis of galbonolide B. J Org Chem 2007,72(24),9387-9390","journal-title":"J Org Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1021\/np4001703","volume":"76","author":"Nirma C.","year":"2013","unstructured":"Nirma C.; Eparvier V.; Stien D.; Antifungal agents from Pseudallescheria boydii SNB-CN73 isolated from a Nasutitermes sp. termite. J Nat Prod 2013,76(5),988-991","journal-title":"J Nat Prod"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1021\/ol101801u","volume":"12","author":"Tae H.S.","year":"2010","unstructured":"Tae H.S.; Hines J.; Schneekloth A.R.; Crews C.M.; Total synthesis and biological evaluation of tyroscherin. Org Lett 2010,12(19),4308-4311","journal-title":"Org Lett"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.3390\/molecules15053507","volume":"15","author":"Hwang B.","year":"2010","unstructured":"Hwang B.; Lee J.; Liu Q.H.; Woo E.R.; Lee D.G.; Antifungal effect of (+)-pinoresinol isolated from Sambucus williamsii. Molecules 2010,15(5),3507-3516","journal-title":"Molecules"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.4014\/jmb.1004.04014","volume":"20","author":"Lee J.","year":"2010","unstructured":"Lee J.; Hwang J-S.; Hwang B.; Kim J-K.; Kim S.R.; Kim Y.; Lee D.G.; Membrane perturbation induced by papiliocin peptide, derived from Papilio xuthus, in Candida albicans. J Microbiol Biotechnol 2010,20(8),1185-1188","journal-title":"J Microbiol Biotechnol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.peptides.2009.07.011","volume":"30","author":"Conlon J.M.","year":"2009","unstructured":"Conlon J.M.; Meetani M.A.; Coquet L.; Jouenne T.; Leprince J.; Vaudry H.; Kolodziejek J.; Nowotny N.; King J.D.; Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae). Peptides 2009,30(10),1775-1781","journal-title":"Peptides"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1021\/np100363a","volume":"73","author":"Tian J.","year":"2010","unstructured":"Tian J.; Shen Y.; Yang X.; Liang S.; Shan L.; Li H.; Liu R.; Zhang W.; Antifungal cyclic peptides from Psammosilene tunicoides. J Nat Prod 2010,73(12),1987-1992","journal-title":"J Nat Prod"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/176182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:13:55Z","timestamp":1579691635000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/176182\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":53,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2019,12,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026619666191025153124","relation":{},"ISSN":["1568-0266"],"issn-type":[{"type":"print","value":"1568-0266"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}